Latest Headlines
-
Comecer To Present Advanced Fill/Finish Technologies At ISPE Annual Meeting
10/24/2025
This year, we are putting the spotlight on our advanced fill-finish technologies, which are designed to address the evolving challenges of pharmaceutical manufacturing with precision, efficiency and reliability.
-
Aseptic Filling OEM AST To Exhibit At CPHI Frankfurt 2025
10/23/2025
From R&D and manufacturing to packaging and distribution, CPHI is where groundbreaking ideas meet the partnerships that bring them to life.
-
U.S. Peptide Manufacturing Capacity Expands As SK Pharmteco Invests In Rancho Cordova Site
10/23/2025
SK pharmteco, a global contract development and manufacturing organization (CDMO), announced today a $6.1 million investment in its Rancho Cordova facility to expand and equip a new lab and CGMP-kilo-scale facility for Solid-Phase Peptide Synthesis (SPPS) and purification. This expansion, combined with SK pharmteco’s industry-leading chromatography expertise and existing development and manufacturing capabilities in the United States, positions the company to meet the rising demand for U.S. peptide development and domestic clinical and commercial manufacturing.
-
Upperton Expands High Precision Filling Capability At Nottingham Facility
10/22/2025
The system has been installed at Upperton’s state-of-the-art 60,000-square-foot GMP facility. The site supports formulation development and clinical manufacturing across a broad range of dosage forms, including oral solids, nasal, pulmonary and parenteral.
-
Cambrex Unveils $120 Million Investment To Expand API Manufacturing And Strengthen U.S. Drug Supply Resilience
10/22/2025
Cambrex, a leading global CDMO, is addressing increased demand for API development and manufacturing and accelerating the company’s leadership role in the fast-growing peptide therapeutics market.
-
Merck Announces Plans For $3 Billion Small Molecule Drug Manufacturing Expansion In Virginia
10/22/2025
Governor Glenn Youngkin announced today that Merck, known as MSD outside of the United States and Canada, is starting construction on a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility that will serve as Merck’s Center of Excellence for Pharmaceutical Ingredients and Small Molecule Manufacturing, and generate 500 jobs at its Elkton, Virginia, site. Merck’s announcement reflects a significant increase beyond the original scope of a $2 billion investment and 300 jobs. The expansion is part of Merck’s $70 billion commitment to domestic research, development, and capital projects.
-
Comecer To Exhibit Aseptic Filling Solutions At ISPE Annual Meeting 2025
10/17/2025
Comecer will be exhibiting at the ISPE Annual Meeting & Expo 2025, on October 26 - 29 at the Charlotte Convention Center in North Carolina, USA.
- 3P Innovation's Fill2Weight Technology Expands High-Precision Filling Capability At The CDMO, Upperton 10/16/2025
-
Ensera Launches As New Brand Identity For SteriPack
10/14/2025
New trading name reflects expanded expertise across design, manufacturing, assembly and packing for global pharma and medical device companies.
-
Jubilant HollisterStier LLC Launches New High-Speed Isolator Based Line, At Its Spokane Manufacturing Facility In The US
10/14/2025
Jubilant Pharmova Limited announced today that Jubilant HollisterStier LLC (JHS)—a wholly owned subsidiary and a leading North American pharmaceutical contract manufacturer, specialising in sterile injectables and serving top global innovator pharma companies—successfully launched its New Sterile Fill & Finish line, third at its Spokane Manufacturing Facility in Washington, US. The launch was marked by the successful production of the inaugural batch, initiating revenue generation from the new Line. This milestone denotes a significant advancement in Jubilant HollisterStier's multi-phase expansion strategy and brings an additional 50% capacity at its Spokane manufacturing facility.